These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 28865603)

  • 1. Independent and additive interaction between polymorphisms of tumor necrosis factor α-308 and lymphotoxin α+252 on risk of hepatocellular carcinoma related to hepatitis B.
    Tsai JF; Chen SC; Lin ZY; Dai CY; Huang JF; Yu ML; Chuang WL
    Kaohsiung J Med Sci; 2017 Sep; 33(9):453-457. PubMed ID: 28865603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent and additive interaction between tumor necrosis factor β +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study.
    Jeng JE; Wu HF; Tsai MF; Tsai HR; Chuang LY; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Tsai JF
    Asian Pac J Cancer Prev; 2014; 15(23):10209-15. PubMed ID: 25556449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactive effects between Lymphotoxin α +252 polymorphism and habits of substance use on risk of hepatocellular carcinoma.
    Tsai JF; Chen SC; Lin ZY; Dai CY; Huang JF; Yu ML; Chuang WL
    Kaohsiung J Med Sci; 2017 Jul; 33(7):334-338. PubMed ID: 28738973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Necrosis Factor Alpha 308 G/A Single Nucleotide Polymorphism and Susceptibility to Hepatocellular Carcinoma Via Hepatitis B Infection.
    Azar SS; Mansoori M; Attar M; Shahbazi M
    Asian Pac J Cancer Prev; 2016; 17(7):3381-4. PubMed ID: 27509979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The MTHFR C677T mutation is not a risk factor recognized for HBV-related HCC in a population with a high prevalence of this genetic marker.
    Jiao X; Luo Y; Yang B; Jing L; Li Y; Liu C; Jing X; Wang F; Wang Y; Du Z; Gao Y
    Infect Genet Evol; 2017 Apr; 49():66-72. PubMed ID: 28082187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus genotypes, expression quantitative trait loci for ZNRD1-AS1 and their interactions in hepatocellular carcinoma.
    Liu Z; Song C; Wen J; Xu L; Liu Y; Zhu J; Zhu L; Hu Z; Ma H; Liu L
    Oncotarget; 2016 Jul; 7(28):44076-44083. PubMed ID: 27286450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor-alpha 308.2 polymorphism is associated with advanced hepatic fibrosis and higher risk for hepatocellular carcinoma.
    Jeng JE; Tsai JF; Chuang LY; Ho MS; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Chang JG
    Neoplasia; 2007 Nov; 9(11):987-92. PubMed ID: 18030367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IkappaBalpha gene promoter polymorphisms are associated with hepatocarcinogenesis in patients infected with hepatitis B virus genotype C.
    He Y; Zhang H; Yin J; Xie J; Tan X; Liu S; Zhang Q; Li C; Zhao J; Wang H; Cao G
    Carcinogenesis; 2009 Nov; 30(11):1916-22. PubMed ID: 19797428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TIM3 gene polymorphisms in patients with chronic hepatitis B virus infection: impact on disease susceptibility and hepatocellular carcinoma traits.
    Li Z; Liu Z; Zhang G; Han Q; Li N; Zhu Q; Lv Y; Chen J; Xing F; Wang Y; Li F
    Tissue Antigens; 2012 Aug; 80(2):151-7. PubMed ID: 22587604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent and additive interactive effects among tumor necrosis factor-alpha polymorphisms, substance use habits, and chronic hepatitis B and hepatitis C virus infection on risk for hepatocellular carcinoma.
    Jeng JE; Tsai HR; Chuang LY; Tsai JF; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Chang JG
    Medicine (Baltimore); 2009 Nov; 88(6):349-357. PubMed ID: 19910749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms of CYP2E1 and DNA repair genes HOGG1 and XRCC1: association with hepatitis B related advanced liver disease and cancer.
    Bose S; Tripathi DM; Sukriti ; Sakhuja P; Kazim SN; Sarin SK
    Gene; 2013 May; 519(2):231-7. PubMed ID: 23454624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of transforming growth factor-β1 and tumor necrosis factor-α genes polymorphisms on the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis C patients.
    Radwan MI; Pasha HF; Mohamed RH; Hussien HI; El-Khshab MN
    Cytokine; 2012 Oct; 60(1):271-6. PubMed ID: 22682513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence.
    Falleti E; Fabris C; Cmet S; Cussigh A; Bitetto D; Fontanini E; Fornasiere E; Bignulin S; Fumolo E; Bignulin E; Pirisi M; Toniutto P
    Liver Int; 2011 Sep; 31(8):1137-43. PubMed ID: 21745286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
    Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G
    Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mannose-binding lectin 2 rs11003123 polymorphism is associated with the development of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis in the Chinese population.
    Wang PS; Kuai J; Li H; Wang CG; Shi BJ; Zhong L
    Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):282-8. PubMed ID: 27298104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three polymorphisms of tumor necrosis factor-alpha and hepatitis B virus related hepatocellular carcinoma: A meta-analysis.
    Xiao Q; Fu B; Chen P; Liu ZZ; Wang W; Ye Q
    Medicine (Baltimore); 2016 Dec; 95(50):e5609. PubMed ID: 27977601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population.
    Kummee P; Tangkijvanich P; Poovorawan Y; Hirankarn N
    J Viral Hepat; 2007 Dec; 14(12):841-8. PubMed ID: 18070287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Factors for Hepatocellular Carcinoma in Cirrhotic Patients with Chronic Hepatitis B.
    Zhang YQ; Peng LJ; Cao YR; Zeng ZP; Wu YJ; Shi H; Cheng SY; Wang JY; Friedman SL; Sninsky JJ; Guo JS
    Genet Test Mol Biomarkers; 2016 Sep; 20(9):535-43. PubMed ID: 27391584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between TNF alpha gene polymorphisms (-238/-308), TNF RII VNTR (p75) and outcomes of hepatitis B virus infection in Tunisian population.
    Sghaier I; Zidi S; Mouelhi L; Dabbech R; Ghazouani E; Brochot E; Stayoussef M; Yacoubi-Loueslati B
    Gene; 2015 Sep; 568(2):140-5. PubMed ID: 25982858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.